Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

Sponsor
Oslo University Hospital
Study ID
NCT02073526
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Drug serum concentrations will be measured at several time-points for inflammatory disease patients treated with anti-TNF agents. The purpose is to determine which patients that will clinically benefit from either discontinue treatment, adjusting the dose, switch to another anti-TNF agent or a different class of medication.

Key Dates

Start date
May 31, 2013
Status verified
Dec 2016
Primary completion
May 31, 2016
Completion
Nov 30, 2016

Study Design

Enrollment
1,230 participants (actual)

Arms

  • Arm: Anti-TNF
    Inflammatory bowel patients age 18 and over treated with anti-TNF agents

Primary Outcome Measure

Measurement of drug serum concentrations [ Time Frame: Serum samples will be collected on average 8 weeks (range 0-90 days) after drug administration ]

Related Studies